Out-of-date browser detected
Your browser appears to be out-of-date, and portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to complete the laboratory development of the remaining two components of a new Shigella 4-valent Synthetic Conjugate Vaccine to prevent Shigella diarrhea and dysentery among children in LMICs.
Grantee
Division
Global Health
Year Awarded
2018
Region Served
GLOBAL
Committed Amount
$593,706
Grant Topic
Enteric and Diarrheal Diseases
Duration (Months)
35
Grantee Location
Paris, France
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.